Study guide

7.3 The Medically Compromised Patient

MFDS Part 1 Membership of the Faculty of Dental Surgery

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

Current Exam Facts How to Use This Guide Eligibility, Booking & the MFDS Pathway

2 Basic Sciences, History Taking & Clinical Assessment

1.1 Head & Neck Anatomy and Underpinning Basic Sciences 1.2 History Taking, Communication & Clinical Examination 1.3 Special Tests, Investigations & Diagnostic Accuracy 1.4 Differential Diagnosis, Triage & When to Biopsy 1.5 Dental Anomalies & Developmental Conditions

3 Cariology, Operative Dentistry & Endodontics

2.1 Cariology & Caries Diagnosis 2.2 Caries Management & Prevention 2.3 Operative Dentistry & Cavity Preparation 2.4 Endodontics 2.5 Tooth Surface Loss & Tooth Discolouration

4 Periodontology & Prosthodontics

3.1 Periodontology 3.2 Fixed Prosthodontics 3.3 Removable Prosthodontics 3.4 Occlusion & Occlusal Assessment

5 Paediatric Dentistry, Orthodontics & Dental Trauma

4.1 Paediatric Dentistry 4.2 Orthodontics 4.3 Dental Trauma 4.4 Orthodontic Assessment, Indices & Referral 4.5 Impacted Teeth & Radiographic Localisation

6 Oral Surgery, Treatment Planning & Prevention

5.1 Oral Surgery & Extractions 5.2 Treatment Planning & Patient Management 5.3 Prevention & Health Promotion

7 Cardiovascular, Respiratory & Endocrine Disease

6.1 Cardiovascular Disease 6.2 Respiratory Disease 6.3 Endocrine Disease & Diabetes 6.4 Bleeding Disorders & Anticoagulation

8 Haematology, Infection & the Medically Compromised Patient

7.1 Haematology 7.2 Infectious Disease 7.3 The Medically Compromised Patient 7.4 Neurological & Gastrointestinal Disease

9 Medical Emergencies in Dental Practice

8.1 Medical Emergencies & Resuscitation 8.2 Anaphylaxis & Acute Allergy 8.3 Emergency Drugs & the Resuscitation Kit

10 Special Care Dentistry, Mental Health & Anxiety Management

9.1 Special Care Dentistry & Patients with Disability 9.2 Mental Health & Behavioural Science 9.3 Dental Anxiety & Behaviour Management

11 Oral Medicine — Mucosal Disease & Orofacial Pain

10.1 Oral Mucosal Disease & Lichen Planus 10.2 Vesiculobullous & Ulcerative Disorders 10.3 Candidiasis & Fungal Infections 10.4 Orofacial Pain & Neuropathic Disorders

12 Oral Pathology — Lesions, Cysts, Tumours & Salivary Glands

11.1 Premalignant Lesions & Oral Cancer 11.2 Odontogenic Cysts 11.3 Odontogenic & Non-Odontogenic Tumours 11.4 Salivary Gland Disease

13 Pharmacology — Local Anaesthesia, Analgesia & Sedation

12.1 Local Anaesthesia 12.2 Analgesics & NSAIDs 12.3 Conscious Sedation

14 Pharmacology — Antimicrobials, Prescribing & Drug Interactions

13.1 Antimicrobials & Antibiotic Stewardship 13.2 Prescribing & Drug Interactions

15 Dental Materials

14.1 Properties & Testing of Dental Materials 14.2 Amalgam & Metal Restorations 14.3 Composite Resin & Adhesive Dentistry 14.4 Impression Materials, Cements & Other Materials

16 Microbiology, Infection Control & Radiology

15.1 Oral Microbiology & Infection Control 15.2 Dental Radiology & Imaging 15.3 Radiation Protection

17 Law, Ethics, Professionalism & Evidence-Based Dentistry

16.1 Consent & Confidentiality 16.2 GDC Standards & Professionalism 16.3 Safeguarding & Duty of Candour 16.4 Evidence-Based Dentistry & Research Methods 16.5 Records, Information Governance & Regulation 16.6 Communication, Teamworking, Human Factors & Raising Concerns

18 Statistics, Dental Public Health, Critical Appraisal & Exam Strategy

17.1 Statistics & Critical Appraisal 17.2 Dental Public Health & Epidemiology 17.3 SBA Technique & Exam Strategy 17.4 Final Review & Key Points

7.3 The Medically Compromised Patient

Key Takeaways Explain This Topic AI

SDCEP classifies MRONJ risk: patients on oral bisphosphonates for less than 5 years with no other risk factors are 'low risk' and can have straightforward extractions in primary care with no specific antibiotic prophylaxis; 'higher risk' includes over 5 years, denosumab within 9 months, cancer treatment, concurrent systemic glucocorticoids or previous MRONJ

For patients on warfarin, check INR within 24 hours of surgery and proceed if INR is 4.0 or below for straightforward extractions using local haemostatic measures; do not stop warfarin without liaison with the prescribing clinician

Schedule dental treatment for haemodialysis patients on a non-dialysis day, avoid the arm with the arteriovenous fistula for blood pressure measurement, and consult the renal team about drug dosing and bleeding risk

Routine dental treatment is safe in pregnancy; the second trimester is preferred for elective work, dental radiography is avoided where possible but a single low-dose periapical radiograph is not a contraindication when clinically justified, and local anaesthetic with epinephrine is safe in standard doses

Patients on long-term systemic corticosteroids may have hypothalamic-pituitary-adrenal suppression; consider the need for steroid cover (additional hydrocortisone) for stressful procedures and consult the prescribing clinician when in doubt

Last updated: August 2026

A Systematic Framework

Whatever the systemic disease, the same structured approach keeps patients safe:

History - medical, drug (including over-the-counter and herbal), allergy, social and family history. Use a structured proforma and ask specifically about bleeding, anaemia, heart, respiratory, renal, liver, endocrine disease, hospital admissions and previous surgical problems.

Risk stratification - assess the impact on bleeding, healing, infection risk, drug interactions and the patient's ability to tolerate the appointment.

Modification - timing of appointment, sedation, LA/GA choice, drug selection, antibiotic or steroid cover, and whether to treat in primary or secondary care.

Seek advice - contact the patient's GP or specialist team when uncertain; document the conversation.

Treat conservatively when risk is high - retain restorable roots, use non-surgical endodontics, postpone elective work.

MRONJ: Medication-Related Osteonecrosis of the Jaw

MRONJ is exposed bone in the maxillofacial region persisting for more than 8 weeks in a patient exposed to an anti-resorptive or anti-angiogenic drug without a history of radiation. UK guidance is from SDCEP (published 2017, reviewed and confirmed as extant in March 2024).

Drugs and Risk Stratification

  • Drug class Examples
  • Bisphosphonates (oral) Alendronic acid, risedronate
  • Bisphosphonates (IV) Zoledronic acid, pamidronate (cancer indications)
  • RANKL inhibitor Denosumab (Prolia, Xgeva)
  • Anti-angiogenic Bevacizumab, sunitinib

Risk category Criteria

Low risk Oral bisphosphonate <5 years; not on denosumab; no cancer; no concurrent systemic glucocorticoids; no previous MRONJ

Higher risk Bisphosphonate >5 years; current denosumab or within last 9 months; cancer treatment; concurrent systemic glucocorticoids; previous MRONJ

Management Principles

Aim for dental fitness before drug commencement - extractions and restorative work completed where possible.

Routine dentistry (restorations, scale and polish, recall) - proceed normally.

Low-risk extractions : perform straightforward extractions in primary care with local measures; no routine antibiotic or antiseptic prophylaxis specifically to prevent MRONJ; review healing at 8 weeks .

Higher-risk extractions : explore all alternatives to extraction (retain roots if infection-free, endodontics, crowning); if extraction remains the most appropriate option, proceed as for low-risk patients and discuss risk for valid consent; consider specialist consultation for medically complex patients; review at 8 weeks.

Do not stop bisphosphonates solely to enable extractions without specialist advice - the drug persists in bone for years.

Refer any patient with spontaneous bone exposure or suspected MRONJ to oral surgery or special care dentistry.

Renal Disease

Chronic kidney disease alters drug excretion, fluid balance and haemostasis.

Haemodialysis Patients

Schedule dental treatment on a non-dialysis day (heparin used during dialysis leaves a residual anticoagulant effect).

Do not measure blood pressure or take blood from the fistula arm.

Risk of endocarditis from the fistula is low but infection control is paramount.

Drug dosing - many dental drugs (including penicillin V, aciclovir, metronidazole) need dose adjustment; consult the BNF or the renal team.

Platelet dysfunction from uraemia raises bleeding risk - consider local measures.

Transplant patients on calcineurin inhibitors (ciclosporin) develop gingival overgrowth ; tacrolimus less so.

Renal Transplant

Dental infection risk is high because of immunosuppression - aggressive prevention.

Prefer non-surgical management; defer routine work for 3-6 months post-transplant when immunosuppression is highest.

Liver Disease

Liver disease impairs synthesis of clotting factors (II, V, VII, IX, X) and produces thrombocytopenia from hypersplenism. The prothrombin time / INR rises and platelets fall.

Check INR and platelet count before invasive treatment in known liver disease.

Proceed for straightforward extractions if INR 4.0 - similar threshold to warfarin - and platelets adequate.

Severe coagulopathy - liaise with hepatology; consider fresh frozen plasma or vitamin K.

Hepatitis B and C - additional cross-infection precautions as for all blood-borne viruses; routine care is appropriate.

Patients with alcohol use disorder - bleeding risk, poor healing, drug interactions; assess capacity and consent carefully.

Pregnancy

Dental treatment is safe in pregnancy. Key principles:

Preferred timing - the second trimester is optimal for elective work; first trimester avoids teratogenic risk; third trimester risks supine hypotension.

Local anaesthetic with epinephrine is safe in standard doses; avoid intravascular injection.

Radiography - avoid where possible; a single low-dose periapical radiograph with a lead apron is not a contraindication when clinically justified.

Medication - paracetamol is first-line analgesic; penicillins, cephalosporins and metronidazole (short course) are generally safe; avoid tetracyclines (tooth staining) and NSAIDs in the third trimester (premature closure of ductus arteriosus).

Position the patient on the left side or with right hip elevated to avoid aortocaval compression.

Elective treatment can be deferred until postpartum if risk is unclear.

The Elderly and Frail Patient

Physiological reserve falls with age. Practical considerations:

Polypharmacy - review interactions and postural hypotension; raise the chair slowly.

Comorbidities - cardiac, respiratory, renal impairment combine.

Cognitive impairment - consent and compliance; shorter appointments.

Xerostomia from anticholinergics, antidepressants and antihypertensives - caries risk, salivary substitutes, fluoride.

Osteoporosis treatment - bisphosphonates (see MRONJ).

Corticosteroid Therapy and Adrenal Suppression

Long-term systemic corticosteroids (e.g. prednisolone >7.5 mg/day for >3 weeks) suppress the hypothalamic-pituitary-adrenal (HPA) axis . Under physiological stress (surgery, infection, trauma) the adrenals may not mount an adequate cortisol response, risking an adrenal crisis - hypotension, hyponatraemia, collapse.

Dental Management

Routine dentistry under local anaesthetic - no additional steroid cover needed.

More stressful procedures - multiple extractions, long surgery - consider supplementary hydrocortisone ; a common UK approach is 100 mg intramuscular or intravenous hydrocortisone at the time of the procedure, but this varies and should follow specialist guidance or the prescribing clinician's advice.

Consult the prescribing clinician if unsure.

Never abruptly stop long-term steroids.

Immunosuppression and Anticoagulants

Immunosuppressed patients - neutropenia and impaired healing; check blood counts, treat infection promptly, aggressive prevention, single course of antibiotics for established infection only (not prophylactic unless local protocol).

Warfarin - check INR within 24 hours of surgery; proceed for straightforward extractions if INR 4.0 using local haemostatic measures (sutures, oxidised cellulose, tranexamic acid 4.8% mouthwash 5 minutes four times daily for 5-7 days); do not stop warfarin without the anticoagulation team.

Direct oral anticoagulants (DOACs) - for apixaban, rivaroxaban, dabigatran, avoid stopping where possible; consult the SDCEP anticoagulant guidance and consider missing one morning dose for higher-risk procedures.

Antiplatelets (aspirin, clopidogrel) - continue for straightforward dental extractions.

When to Treat in Secondary Care

Refer or treat in a hospital setting when:

Significant uncontrolled systemic disease (recent MI, unstable angina, severe heart failure).

Severe bleeding risk not manageable with local measures.

Need for general anaesthesia or sedation beyond primary care scope.

Complex MRONJ, established osteoradionecrosis, or extensive maxillofacial infection.

Patients on complex chemotherapy regimens or within the intensive immunosuppression window after transplant.

Pregnancy with obstetric complications or where specialist input is required.

When in doubt, seek medical advice first - document who gave it and when.